160 related articles for article (PubMed ID: 12552504)
1. The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population.
Rubel JR; Milford EL
Am J Kidney Dis; 2003 Feb; 41(2):411-21. PubMed ID: 12552504
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery.
Yan H; Sharma J; Weber CJ; Guyton RA; Perez S; Thourani VH
Surgery; 2011 Dec; 150(6):1095-101. PubMed ID: 22136827
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients.
Stack AG; Bloembergen WE
Am J Kidney Dis; 2001 Nov; 38(5):992-1000. PubMed ID: 11684552
[TBL] [Abstract][Full Text] [Related]
5. Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients: a cross-sectional study.
Lee CT; Tsai YC; Ng HY; Su Y; Lee WC; Lee LC; Chiou TT; Liao SC; Hsu KT
J Ren Nutr; 2009 May; 19(3):220-7. PubMed ID: 19243976
[TBL] [Abstract][Full Text] [Related]
6. The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
Habib AN; Baird BC; Leypoldt JK; Cheung AK; Goldfarb-Rumyantzev AS
Nephrol Dial Transplant; 2006 Oct; 21(10):2881-92. PubMed ID: 16735386
[TBL] [Abstract][Full Text] [Related]
7. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
Phelan PJ; O'Kelly P; Walshe JJ; Conlon PJ
Ren Fail; 2008; 30(4):423-9. PubMed ID: 18569917
[TBL] [Abstract][Full Text] [Related]
8. [The impact of changes in levels of calcium, phosphate and magnesium during hemodialysis on autonomic system reactivity as measured by heart rate variability analysis].
Buda S; Stompór T; Sułowicz W; Kopeć J; Szymczakiewicz-Multanowska A; Janion M
Przegl Lek; 2000; 57(6):340-5. PubMed ID: 11107869
[TBL] [Abstract][Full Text] [Related]
9. Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients.
Unruh ML; Evans IV; Fink NE; Powe NR; Meyer KB;
Am J Kidney Dis; 2005 Dec; 46(6):1107-16. PubMed ID: 16310577
[TBL] [Abstract][Full Text] [Related]
10. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
Rudnicki M; Frølich A; Haaber A; Tvedegaard E; Thode J
Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders.
Sturtevant JM; Hawley CM; Reiger K; Johnson DW; Campbell SB; Burke JR; Bofinger A; Isbel NM
Nephrology (Carlton); 2004 Dec; 9(6):406-13. PubMed ID: 15663645
[TBL] [Abstract][Full Text] [Related]
12. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.
Lacson E; Wang W; Hakim RM; Teng M; Lazarus JM
Am J Kidney Dis; 2009 Jan; 53(1):79-90. PubMed ID: 18930570
[TBL] [Abstract][Full Text] [Related]
13. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
[TBL] [Abstract][Full Text] [Related]
14. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
15. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
[TBL] [Abstract][Full Text] [Related]
16. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
[TBL] [Abstract][Full Text] [Related]
17. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
Wang AY; Woo J; Sea MM; Law MC; Lui SF; Li PK
Am J Kidney Dis; 2004 Apr; 43(4):712-20. PubMed ID: 15042549
[TBL] [Abstract][Full Text] [Related]
18. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
Menon V; Greene T; Pereira AA; Wang X; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
Am J Kidney Dis; 2005 Sep; 46(3):455-63. PubMed ID: 16129207
[TBL] [Abstract][Full Text] [Related]
19. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
Hwang JC; Chen CA; Wang CT; Chen HC
Ren Fail; 2008; 30(10):943-51. PubMed ID: 19016144
[TBL] [Abstract][Full Text] [Related]
20. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
